[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:hr-low-positive-her2-negative-breast-neoplasms":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"HR Low-Positive\u002FHER2-Negative Breast Neoplasms",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06966700","A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)",[11],"Phase 3","RECRUITING","2026-08-26T02:15:01.639696Z","2026-07-05T05:32:16.724482Z",[],[]]